Portfolio company
Revanta
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Revanta develops an artificial intelligence platform for drug design to support biotechnology companies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Revona Bio
The company develops an RNA-targeted drug discovery platform to identify small-molecule compounds for pharmaceutical partners and biotechnology firms.
Reverie Labs
The company develops machine learning software to design small-molecule kinase inhibitors for pharmaceutical firms and research institutions.
Duplicat
This company develops artificial intelligence technology to accelerate molecular discovery and enhance drug compound identification for pharmaceutical businesses.
Computational drug discovery platform
This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.
Variartional
This company develops generative artificial intelligence to accelerate the discovery and optimization of novel small molecules for biopharmaceutical researchers and drug developers.
ReactWise
ReactWise develops an artificial intelligence platform for chemical process optimization used by pharmaceutical and biotechnology companies to accelerate research and development workflows.
